Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
The American Journal of Medicine
|
August 20, 2013
Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes
Stuart A Ross
Current Medical Research and Opinion
|
October 10, 2014
A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes
Stuart A Ross
Diabetes Research and Clinical Practice
|
August 19, 2004
Controlling diabetes: the need for intensive therapy and barriers in clinical management
Stuart A Ross
Current Medical Research and Opinion
|
August 27, 2013
Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes
Stuart A Ross, Jane Ballantine
Canadian Family Physician Medecin De Famille Canadien
|
July 16, 2010
Incretin agents in type 2 diabetes
Stuart A Ross, Jean-Marie Ekoé
Current Medical Research and Opinion
|
September 28, 2011
Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes
Stuart A Ross, Hugh D Tildesley, John Ashkenas
Diabetes Care
|
July 30, 2010
Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin
Hugh D Tildesley, Adel B Mazanderani, Stuart A Ross
The Medical Clinics of North America
|
December 3, 2014
Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic review
Hugh D Tildesley, Michelle D Po, Stuart A Ross
Experimental Diabetes Research
|
March 5, 2008
Diabetic retinopathy in native and nonnative Canadians
Stuart A Ross, Anne McKenna, Sheila Mozejko, et al.
Neuroscience Letters
|
January 22, 2008
Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats
Randy L Hunter, Dong-Young Choi, Stuart A Ross, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
The American Journal of Medicine
|
August 20, 2013
Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes
Stuart A Ross
Current Medical Research and Opinion
|
October 10, 2014
A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes
Stuart A Ross
Diabetes Research and Clinical Practice
|
August 19, 2004
Controlling diabetes: the need for intensive therapy and barriers in clinical management
Stuart A Ross
Current Medical Research and Opinion
|
August 27, 2013
Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes
Stuart A Ross, Jane Ballantine
Canadian Family Physician Medecin De Famille Canadien
|
July 16, 2010
Incretin agents in type 2 diabetes
Stuart A Ross, Jean-Marie Ekoé
Current Medical Research and Opinion
|
September 28, 2011
Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes
Stuart A Ross, Hugh D Tildesley, John Ashkenas
Diabetes Care
|
July 30, 2010
Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin
Hugh D Tildesley, Adel B Mazanderani, Stuart A Ross
The Medical Clinics of North America
|
December 3, 2014
Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic review
Hugh D Tildesley, Michelle D Po, Stuart A Ross
Experimental Diabetes Research
|
March 5, 2008
Diabetic retinopathy in native and nonnative Canadians
Stuart A Ross, Anne McKenna, Sheila Mozejko, et al.
Neuroscience Letters
|
January 22, 2008
Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats
Randy L Hunter, Dong-Young Choi, Stuart A Ross, et al.
Page
of 4